EODData

MEMBERSHIP REGISTER LOG IN

FRA, NB3: Neurocrine Biosciences Inc

23 Dec 2025
LAST:

124.1

CHANGE:
 1.55		OPEN:
124.1		HIGH:
124.1		ASK:
0.0		VOLUME:
10
CHG(%):
1.27		PREV:
122.5		LOW:
124.1		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Dec 25124.1124.1124.1124.110
22 Dec 25122.5122.5122.5122.5248
19 Dec 25119.8119.8119.8119.8248
18 Dec 25119.7119.7119.7119.7248
17 Dec 25126.1126.1126.1126.1248
16 Dec 25129.8129.8129.8129.8248
15 Dec 25129.3129.3129.3129.3248
12 Dec 25130.8130.8130.8130.8248
11 Dec 25131.7131.7131.7131.7248
10 Dec 25132.8132.8132.8132.8248

PROFILE

Name:Neurocrine Biosciences Inc
About:Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Sector:Healthcare
Address:12780 El Camino Real, San Diego, CA, United States, 92130
Website:https://www.neurocrine.com
ISIN:US64125C1099
LEI:549300FECER0XBN49756

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:34.01 
Forward P/E:31.89 
PEG Ratio:0.48 
Price to Sales:4.76 
Price to Book:4.09 
Profit Margin:0.16 
Operating Margin:0.30 
Return on Assets:0.09 
Return on Equity:0.15 
Revenue:2.328B 
EBITDA:428.4M 
Shares:99.18M 
Market Cap:12.303B 

TECHNICAL INDICATORS

MA5:122.421.3%
MA10:126.642.1%
MA20:128.333.5%
MA50:125.401.1%
MA100:121.062.5%
MA200:112.4610.3%
STO9:36.67
STO14:24.38
RSI14:38.88 
WPR14:-70.76
MTM14:-5.15
ROC14:-0.04 
ATR:2.18 
Week High:129.754.6%
Week Low:119.653.7%
Month High:137.7011.0%
Month Low:119.6510.3%
Year High:148.6919.9%
Year Low:77.9959.1%
Volatility:16.70